Fig. S1
. UV-driven photolysis of 3β-hydroxyandrosta-5,7-diene (5b) and time dependent isomerization of products.
(a) RP-HPLC separation of 5b irradiation products after treatment with UVB for 15 minutes. The sample was incubated in the dark, at room temperature (20°C) for 1 hour or 1, 2, 3, or 7 days after irradiation. . The UV-driven photolysis of 3β,17 β -hydroxypregna-5,7-dien-20-one (5a) and time dependent isomerization of products.
(a) RF-HPLC separation of 5a irradiation products after treatment with UVB for 15 minutes. The sample was incubated in the dark, at room temperature (20°C) for 1 hour or 1, 2, 3, or 7 days after irradiation. (b) Representative UV spectra of irradiated samples. (1 -5a-iT, 2-5a, 3-5a-D, 4 -5a-L, 7 -5a-T, 9 -5a-pD). (c) The changes in relative amount of substrate and products during incubation after irradiation at 20°C. The changes are expressed as a ratio of total area under the selected peak to the total area of peaks in percent. The UV spectra for RP-HPLC (Panel a) were measured at 280 nm. . Proton NMR spectra of androsta-and pregna-5,7-dienes and main products of their irradiation with 5a as an example.
(a) 3β,17α-dihydroxypregna-5,7-dien-20-one (5a), (b) 3β,17α-dihydoxy-9β,10α-pregna-5,7-dien-20-one (5a-L) (c) 5Z,7E-3β,17α-dihydroxy-9,10-secopregna-5,7,10(19)trien-20-one (5a-D) (d) 6E-3β,17α-dihydroxy-9,10-secopregna-5(10),6,8-trien-20-one (5a-T). The main peaks used for structural identification of compounds are marked by number of carbon. Impurities and solvents are described or marked with a star (*). 
